Alerts
Other content recommended for you
- Cholinesterase inhibitors and memantine for symptomatic treatment of dementia
- Prediction of treatment response to rivastigmine in Alzheimer’s dementia
- Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease
- The cholinergic hypothesis of Alzheimer’s disease: a review of progress
- Treatment of dementia
- Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
- Alzheimer’s disease
- ▼Rivastigmine for Alzheimer's disease
- Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study